Falcon Technic Welcomes First Third-Party Maintenance Client: Bombardier Global 5000
DUBAI, United Arab Emirates, May 07, 2025 (GLOBE NEWSWIRE) — Falcon, part of Alex Group Investment, is excited to announce a major development for Falcon Technic, our MRO division (Maintenance, Repair, and Overhaul): we have welcomed our first third–party maintenance client, a Bombardier Global 5000 aircraft.
This marks a key step in expanding our services and growing as a trusted partner...
Falcon Expands Fleet with Two New Legacy 650 Aircraft
DUBAI, United Arab Emirates, May 07, 2025 (GLOBE NEWSWIRE) — Falcon, part of Alex Group Investment, is proud to announce the addition of two Legacy 650 aircraft to its fleet.
These aircraft offer spacious cabins designed for maximum comfort and privacy, making them ideal for both business and leisure travel. With an impressive range, they can fly non–stop from London to New York, Paris...
Zoom and ServiceNow Announce Strategic Integration to Elevate Customer and Employee Experiences
LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) — Zoom Communications Inc. (NASDAQ: ZM) and ServiceNow (NYSE: NOW), the AI platform for business transformation, today announced plans to integrate Zoom CX with ServiceNow CRM and IT Service Management (ITSM). The integration, announced as part of Knowledge 2025, ServiceNow’s annual customer and partner event, will deliver a turnkey, AI–first...
Your World empowers young people to become leaders and agents of change
This year’s national winners from Royal International School, Kurunegala in Sri Lanka focused on a new initiative at their school, enabling students to benefit from outdoor learning.
The first and second runner–up winners, selected from the national entries, were Brisbane International School and Musaeus College. On a global scale, 642 entries were submitted by 3,210 students from 34 countries.
Participants...
Your World Empowers Young People to Become Leaders and Agents of Change
The winner of the 2025 Your World competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries.
Participants gain crucial skills in problem–solving, communication, and creativity, preparing them to tackle some of...
Your World Empowers Young People to Become Leaders and Agents of Change
The winner of the 2025 ‘Your World’ competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries.
Participants gain crucial skills in problem–solving, communication, and creativity, preparing them to tackle...
Your World Empowers Young People to Become Leaders and Agents of Change
The winner of the 2025 Your World competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries.
Participants gain crucial skills in problem–solving, communication and creativity, preparing them to tackle some of the world’s...
Your World Empowers Young People to Become Leaders and Agents of Change
The winner of the 2025 ‘Your World’ competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries.
Participants gain crucial skills in problem–solving, communication, and creativity, preparing them to tackle...
Dr. Falk Pharma gibt positive Ergebnisse seiner zulassungs-relevanten Phase-III-Studie zu Norucholsäure bei primär sklerosierender Cholangitis bekannt
Freiburg, den 7. Mai 2025
Die Studienergebnisse zeigen die Überlegenheit von Norucholsäure (NCA) gegenüber Placebo im kombinierten primären Endpunkt. Es gibt derzeit kein zugelassenes Arzneimittel zur Behandlung von primär sklerosierender Cholangitis. Die Ergebnisse der Studie NUC–5 nach 96 Wochen der Analyse werden auf dem EASL–Kongress 2025 in Amsterdam vorgestellt.
Dr....
Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis
Freiburg, May 7th, 2025
Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96–week analysis of the NUC–5 trial will be presented at 2025 EASL Congress in Amsterdam.
Dr. Falk Pharma, a research–based pharmaceutical company...
Lebanese Pound Exchange Rate